Two Sigma Investments’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,688
Closed -$238K 4323
2025
Q3
$238K Sell
30,688
-2,243
-7% -$16.8K ﹤0.01% 3312
2025
Q2
$244K Buy
32,931
+30,785
+1,435% +$271K ﹤0.01% 2858
2025
Q1
$18.5K Sell
2,146
-6,289
-75% -$97K ﹤0.01% 3110
2024
Q4
$302K Sell
8,435
-3,574
-30% -$185K ﹤0.01% 2733
2024
Q3
$567K Sell
12,009
-17,939
-60% -$791K ﹤0.01% 2407
2024
Q2
$1.5M Buy
29,948
+21,230
+244% +$1.53M ﹤0.01% 1749
2024
Q1
$976K Buy
8,718
+1,864
+27% +$185K ﹤0.01% 1972
2023
Q4
$398K Buy
6,854
+891
+15% +$35.8K ﹤0.01% 2569
2023
Q3
$189K Sell
5,963
-4,728
-44% -$225K ﹤0.01% 2651
2023
Q2
$879K Buy
10,691
+2,508
+31% +$367K ﹤0.01% 2007
2023
Q1
$841K Sell
8,183
-16,530
-67% -$2.32M ﹤0.01% 1956
2022
Q4
$3.62M Sell
24,713
-2,570
-9% -$434K 0.01% 1017
2022
Q3
$4.61M Buy
27,283
+9,236
+51% +$1.5M 0.02% 789
2022
Q2
$2.08M Sell
18,047
-32,978
-65% -$3.1M 0.01% 1181
2022
Q1
$5.09M Buy
51,025
+15,915
+45% +$1.86M 0.02% 921
2021
Q4
$5.46M Buy
35,110
+21,180
+152% +$4.12M 0.01% 1148
2021
Q3
$3.28M Sell
13,930
-8,631
-38% -$2.52M 0.01% 1540
2021
Q2
$7.66M Buy
22,561
+7,138
+46% +$2.7M 0.02% 961
2021
Q1
$6.24M Buy
15,423
+7,490
+94% +$3.63M 0.02% 928
2020
Q4
$5.28M Buy
7,933
+1,222
+18% +$680K 0.02% 902
2020
Q3
$3.12M Sell
6,711
-2,064
-24% -$1.04M 0.01% 1048
2020
Q2
$5.13M Buy
8,775
+5,727
+188% +$1.96M 0.03% 632
2020
Q1
$444K Buy
3,048
+1,820
+148% +$318K ﹤0.01% 2027
2019
Q4
$176K Sell
1,228
-3,438
-74% -$251K ﹤0.01% 3450
2019
Q3
$184K Buy
4,666
+3,481
+294% +$253K ﹤0.01% 3215
2019
Q2
$120K Sell
1,185
-1,567
-57% -$185K ﹤0.01% 3181
2019
Q1
$362K Buy
2,752
+35
+1% +$4.4K ﹤0.01% 2474
2018
Q4
$277K Buy
+2,717
New +$430K ﹤0.01% 2506

Other funds holding MRSN